These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36040712)

  • 1. Exposure to leucine alters glutamate levels and leads to memory and social impairment in zebrafish.
    da Silva Lemos I; Wessler LB; Duarte MB; da Silva GL; Bernardo HT; Candiotto G; Torres CA; Petronilho F; Rico EP; Streck EL
    Metab Brain Dis; 2022 Dec; 37(8):2925-2935. PubMed ID: 36040712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
    Amaral AU; Wajner M
    Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin improves behavioral parameters and oxidative stress in zebrafish submitted to a leucine-induced MSUD protocol.
    Duarte MB; Medeiros BZ; da Silva Lemos I; da Silva GL; Alano CG; Dondossola ER; Torres CA; Effting PS; Rico EP; Streck EL
    Metab Brain Dis; 2023 Aug; 38(6):2105-2114. PubMed ID: 37099078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Piri-Moghadam H; Miller A; Pronger D; Vicente F; Charrow J; Haymond S; Lin DC
    Methods Mol Biol; 2022; 2546():65-81. PubMed ID: 36127579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
    Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
    Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
    Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR
    Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
    Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
    Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-carnitine Prevents Oxidative Stress in the Brains of Rats Subjected to a Chemically Induced Chronic Model of MSUD.
    Mescka CP; Rosa AP; Schirmbeck G; da Rosa TH; Catarino F; de Souza LO; Guerreiro G; Sitta A; Vargas CR; Dutra-Filho CS
    Mol Neurobiol; 2016 Nov; 53(9):6007-6017. PubMed ID: 26526843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to leucine induces oxidative stress in the brain of zebrafish.
    de Medeiros BZ; Wessler LB; Duarte MB; Lemos IS; Candiotto G; Canarim RO; Dos Santos PCL; Torres CA; Scaini G; Rico EP; Generoso JS; Streck EL
    Metab Brain Dis; 2022 Apr; 37(4):1155-1161. PubMed ID: 35275349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in plasma from maple syrup urine disease patients during treatment.
    Barschak AG; Sitta A; Deon M; Barden AT; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2008 Mar; 23(1):71-80. PubMed ID: 18026828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease.
    Friedrich T; Lambert AM; Masino MA; Downes GB
    Dis Model Mech; 2012 Mar; 5(2):248-58. PubMed ID: 22046030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease.
    Tavares RG; Santos CE; Tasca CI; Wajner M; Souza DO; Dutra-Filho CS
    J Neurol Sci; 2000 Dec; 181(1-2):44-9. PubMed ID: 11099711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute exposure to leucine modifies behavioral parameters and cholinergic activity in zebrafish.
    Wessler LB; Farias HR; Ronsani JF; Candiotto G; Dos Santos PCL; de Oliveira J; Rico EP; Streck EL
    Int J Dev Neurosci; 2019 Nov; 78():222-226. PubMed ID: 31589917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
    Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
    Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease.
    Morais FA; Lemos IS; Matiola RT; Freitas MLS; Alano CG; Cabral J; Wessler LB; Generoso JS; Scaini G; Réus GZ; Streck EL
    Metab Brain Dis; 2022 Jun; 37(5):1585-1596. PubMed ID: 35394251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maple syrup urine disease: magnetic resonance imaging findings in three patients.
    Allahwala A; Ahmed S; Afroze B
    J Pak Med Assoc; 2021 Apr; 71(4):1309-1313. PubMed ID: 34125801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
    Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro.
    Pilla C; Cardozo RF; Dutra-Filho CS; Wyse AT; Wajner M; Wannmacher CM
    Neurochem Res; 2003 May; 28(5):675-9. PubMed ID: 12716015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain amino acid requirements and toxicity: the example of leucine.
    Yudkoff M; Daikhin Y; Nissim I; Horyn O; Luhovyy B; Luhovyy B; Lazarow A; Nissim I
    J Nutr; 2005 Jun; 135(6 Suppl):1531S-8S. PubMed ID: 15930465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.